BioHealth News Archive
Cellphire Therapeutics Names Michael Gaffney as Company’s New CEO
ROCKVILLE, Md., April 20, 2021 /PRNewswire/ -- Cellphire Therapeutics, Inc., a biotechnology company developing next-generation platelet-based hemostatic therapeutics for application across multiple medical indications,…
Read MoreFederal Laboratory Consortium for Technology Transfer Archives · BioBuzz
The Montgomery County Economic Development Corporation (MCEDC) and the Federal Laboratory Consortium (FLC) have signed a Memorandum of Understanding (MOU) to formalize a strategic…
Read MoreTEDCO’s Seed Fund Invests $200K in Maryland Technology Startup, Completing $850K Investment Round | TEDCO
COLUMBIA, Md. (April 20, 2021)—TEDCO, Maryland’s economic engine for technology companies, announced today its Seed Fund invested $200K in TargetDocs, a Maryland-based technology startup.…
Read MoreLargest Venture Capital Investors in Greater D.C. – Washington Business Journal
Largest Venture Capital Investors in Greater D.C. - Washington Business Journal Image: https://www.bizjournals.com {iframe}https://www.bizjournals.com/washington/subscriber-only/2021/04/23/largest-venture-capital-investors-in.html{/iframe}
Read MoreFDA approves GSK’s endometrial cancer therapy – MarketWatch
U.S.-listed shares of GlaxoSmithKline GSK, 0.12% were down 1.4% in trading on Thursday after the Food and Drug Administration said it had granted accelerated…
Read MoreChinese diagnostics company expands business to Maryland amid pandemic | Maryland Business News
Amid the international effects of the COVID-19 pandemic, Maccura Biotechnology, headquartered in the city of Chengdu in China’s Sichuan Province, is still able to…
Read MoreBethesda’s Gain Therapeutics Announces Multi-Target Drug Discovery Collaboration Agreement with Zentalis Pharmaceuticals · BioBuzz
BETHESDA, Md., April 20, 2021 (GLOBE NEWSWIRE) — Gain Therapeutics, Inc. (NASDAQ: GANX) (“Gain”) today announced a multi-target collaboration agreement with Zentalis Pharmaceuticals (NASDAQ:…
Read MoreUnited Therapeutics submits new drug application to FDA to treat pulmonary arterial hypertension | WRAL TechWire
RESEARCH TRIANGLE PARK — United Therapeutics has applied for a priority review voucher and submitted a new drug application to the United States Food and…
Read MoreJLABS companies aren’t slowing down
Each quarter we bring you an update from our Johnson & Johnson Innovation – JLABS Portfolio of companies across our 13 sites, from San…
Read MoreNexImmune Appoints Chad Rubin as Senior Vice President, Corporate Affairs Nasdaq:NEXI
GAITHERSBURG, Md., April 21, 2021 (GLOBE NEWSWIRE) -- NexImmune, Inc. (Nasdaq: NEXI), a clinical-stage biotechnology company developing a novel approach to immunotherapy designed to orchestrate…
Read MoreQiagen Nabs CE Mark for High-Throughput SARS-CoV-2 Test Kit | Genomeweb
NEW YORK – Qiagen said on Tuesday that it has received a CE-IVD mark for its Artus SARS-CoV-2 Prep&Amp UM Kit for high-throughput PCR-based…
Read MoreQuantum Startup Foundry: Energizing innovative companies to bring quantum technologies to market.
The Quantum Startup Foundry (QSF) at the University of Maryland brings together the resources needed—physical and virtual—to support entrepreneurs and startups in accelerating quantum…
Read MoreTop bipartisan group relaunches $110 billion technology bill – Roll Call
A group of top lawmakers of both parties in both chambers of Congress on Wednesday reintroduced legislation that aims to spend $110 billion on…
Read MoreAs biotech demand surges, Matan Cos. plans new development in Montgomery County – Washington Business Journal
The Matan Cos. will add biotech manufacturing and research space to one of its existing office campuses in Germantown to meet the surge in…
Read MoreRevisiting SBIR and Other Non-Dilutive Funding Sources Workshop
Did you miss our 3-day Workshop featuring experts from NIH, HHS, NCI, NSF, USAMRDC, NIA, MTech, BHI, and others? Videos and Slide decks are…
Read More